Cube Pharmaceuticals: Obtained Registration Certificate for the American Losartan Potassium Tablets.

Cube Pharmaceuticals announced on May 22 that the company has received the Drug Registration Certificate for the telmisartan potassium tablets approved and issued by the National Medical Products Administration. This drug is used for the treatment of primary hypertension in adults.